1. Triple-sequential defibrillation for refractory ventricular fibrillation in a 24-year-old male out of hospital cardiac arrest
- Author
-
Adam Bignucolo, Dominique Ansell, John Kusnierczyk, Adam Parent, Mark Dube, and Robert Ohle
- Subjects
medicine.medical_specialty ,business.industry ,Defibrillation ,medicine.medical_treatment ,Advanced cardiac life support ,030208 emergency & critical care medicine ,Return of spontaneous circulation ,medicine.disease ,Esmolol ,Coronary artery disease ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Ventricular fibrillation ,Emergency Medicine ,medicine ,Cardiology ,030212 general & internal medicine ,Myocardial infarction ,Cardiopulmonary resuscitation ,business ,medicine.drug - Abstract
SUMMARYRefractory ventricular fibrillation encountered during cardiac arrest has a mortality rate of 97%.1 As per the advanced cardiac life support (ACLS) guidelines, the management algorithm of ventricular fibrillation consists of chest compressions, epinephrine, defibrillation, and anti-arrhythmics.2 There have been reports describing the use of the fast-acting selective β-blocker, esmolol, and dual-sequential defibrillation in the management of ventricular fibrillation that is refractory to standard ACLS. We present a case of a 24-year-old male who had an out-of-hospital cardiac arrest, with refractory ventricular fibrillation despite high-quality cardiopulmonary resuscitation (CPR) and ACLS management. Along with standard ACLS, triple-sequential defibrillation was used to achieve return of spontaneous circulation (ROSC) after 82 minutes of downtime. An electrocardiogram (ECG) after ROSC showed an ST-elevation myocardial infarction (MI), and the patient underwent angiography showing a 100% occlusion of his left anterior descending artery. Following management of his coronary artery disease, he was discharged from the hospital 16 days later and was neurologically intact.
- Published
- 2022